About
Adicet Bio develops allogeneic gamma delta T cell therapies for the treatment of autoimmune diseases and cancer, focusing on off-the-shelf immune cell therapies using proprietary CAR T technology.
Explore Adicet Bio, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.